160 related articles for article (PubMed ID: 14669839)
1. Alternatives for optimal hormone replacement therapy.
Sitruk-Ware R
Climacteric; 2003 Aug; 6 Suppl 2():11-6. PubMed ID: 14669839
[TBL] [Abstract][Full Text] [Related]
2. The role of antiandrogens in hormone replacement therapy.
Schneider HP
Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
[TBL] [Abstract][Full Text] [Related]
3. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
[TBL] [Abstract][Full Text] [Related]
4. Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.
Foidart JM; Faustmann T
Gynecol Endocrinol; 2007 Dec; 23(12):692-9. PubMed ID: 18075844
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
von Schoultz B
Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of estradiol valerate/dienogest.
Teichmann A
Climacteric; 2003 Aug; 6 Suppl 2():17-23. PubMed ID: 14669840
[TBL] [Abstract][Full Text] [Related]
7. [Selective estrogen receptor modulators as a new concept in preventing health risks of menopause].
Vokrouhlická J; Pavo I; Stĕpán J
Cas Lek Cesk; 1998 Nov; 137(22):679-85. PubMed ID: 9929934
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials.
Zec RF; Trivedi MA
Climacteric; 2002 Jun; 5(2):122-34. PubMed ID: 12051107
[TBL] [Abstract][Full Text] [Related]
10. Current trends in hormone replacement therapy: perceptions and usage.
Birkhäuser MH; Reinecke I
Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
[TBL] [Abstract][Full Text] [Related]
11. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
12. The rationale for a wider range of progestogens.
Skouby SO
Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
[TBL] [Abstract][Full Text] [Related]
13. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
14. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
15. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy. An analysis of efficacy based on evidence.
Gupta G; Aronow WS
Geriatrics; 2002 Aug; 57(8):18-20, 23-4. PubMed ID: 12201226
[TBL] [Abstract][Full Text] [Related]
17. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
18. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
19. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
Haskell SG
J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
[TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy: from women's choice to women's preference.
Lachowsky M
Climacteric; 2002 Jun; 5 Suppl 2():46-9. PubMed ID: 12482111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
